Table 2.
Gene | Clan/family | Transcript ID 1 | Log2 fold Change 2 |
---|---|---|---|
Phase I- P450 | |||
CYP18A1 | CYP2 | contig_9694 | 3.43 |
CYP380C10 | CYP4 | contig_11996 | 1.28 |
CYP4CJ1 | CYP4 | contig_16027 | 2.54 |
contig_16409 | 2.35 | ||
CYP4CJ2 | CYP4 | contig_4861 | 1.15 |
CYP6CY7 | CYP3 | contig_6786 | 0.89 |
CYP6CY18 | CYP3 | contig_10526 | 1.47 |
CYP6CY12 | CYP3 | contig_37882 | 2.23 |
CYP6CY9 | CYP3 | contig_14185 | 2.57 |
CYP6DA2 | CYP3 | contig_14387 | 2.02 |
CYP6CY12 | CYP3 | contig_14831 | 1.54 |
CYP6CY? | CYP3 | contig_2862 | 1.86 |
CYP6DA2 | CYP3 | contig_14561 | 1.25 |
CYP6CY9 | CYP3 | contig_2861 | 1.46 |
contig_15324 | 2.12 | ||
Phase II | |||
Glutathione-s-transferase | D1 | contig_3571 | 1.36 |
Carboxyesterase | 3 | contig_18013 | 1.59 |
γ-Glutamyltranspeptidase | 1 | contig_13012 | 1.78 |
Sulfotransferase | C4 | contig_17526 | 1.57 |
Phase III- ABC transporter | |||
AyABC1 | G | contig_9851 | 2.70 |
AyABC2 | G | contig_1566 | 0.81 |
AyABC3 | G | contig_10797 | 1.54 |
AyABC4 | G | contig_24607 | 1.74 |
AyABC5 | G | contig_21800 | 1.54 |
AyABC6 | G | contig_10798 | 1.27 |
AyABC7 | D | contig_6659 | 0.93 |
AyABC8 | G | contig_38300 | 1.87 |
AyABC9 | G | contig_7807 | 1.24 |
AyABC10 | G | contig_15965 | 1.50 |
Others | |||
Scavenger receptor | |||
AySR1 | B | contig_4343 | 1.77 |
AySR2 | B | contig_11991 | 1.35 |
AySR3 | B | contig_13127 | 1.41 |
AySR4 | B | contig_41556 | 2.21 |
Nose resistant to fluoxetine | |||
AyNRF1 | contig_12910 | 1.81 | |
AyNRF2 | contig_8994 | 2.46 | |
AyNRF3 | contig_25819 | 1.54 | |
AyNRF4 | contig_2364 | 1.72 | |
AyNRF5 | contig_5415 | 1.06 | |
AyNRF6 | contig_11008 | 1.58 | |
AyNRF7 | contig_37766 | 2.13 |
1Nucleotide sequence for each contig is provided in Additional file 9.
2Fold change values for gene expression were considered significant if P <0.05.